NYSE:HIMSHealthcare
Hims & Hers Health (HIMS) Margins Worsen As Q1 Loss Resurfaces And Tests Bullish Narratives
Hims & Hers Health (HIMS) opened Q1 2026 with revenue of US$608.1 million and a reported loss of US$92.1 million, equal to EPS of US$0.40 in the red. The company has seen quarterly revenue move from US$481.1 million in Q4 2024 to the US$544.8 million to US$617.8 million range through 2025. EPS shifted from US$0.12 to US$0.22 of profit in early 2025 before slipping back into a loss in the latest quarter. This sets up a results season in which investors will be weighing top line scale against...